| English Alias: |
(R)-Zanubrutinib;(R)-BGB-3111;Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 4,5,6,7-tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)-, (7R)-;Zanubrutinib Impurity 1 ((R)-Zanubrutinib);MS-28722;BZ170196;E77326;(R)-BGB-3111; (R)-BGB 3111; (R)-BGB3111;CHEMBL4107402;US9447106, 27a (peak 1);J5UMF98KEY;(7R)-4,5,6,7-Tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide;(S)-Zanubrutinib;SCHEMBL22159617;Zanubrutinib, (R)-;BCP30082;SCHEMBL18090709;AKOS040740645;BDBM250081;(7R)-2-(4-phenoxyphenyl)-7-[1-(prop-2-enoyl)piperidin-4-yl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-3-carboxamide;1691249-44-1;CS-0021870;(7R)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide;DA-59625;HY-101474B;EX-A3705 |